Since 1996, the net economic benefit of crop biotechnology at the farm level has been $133.5 billion. In a previous post, we asked Zintro experts to share their thoughts about the report GM crops: global socio-economic and environmental impacts 1996-2013. Let’s look at two more responses.

Jimm Grimm is the Owner and Chief Consultant of JHG Associates, a plastics and coatings consultant business. “Growing GMO crops is a two sided coin,” says Grimm. “Both sides must be considered. On the bright side, there is no doubt that you can get much more production with a lot less labor. These short-term gains are very impressive; so the method has been adopted widely. The promoters have documented financial advantages, and this information is readily available. On the less bright side, farmers lose control of where their seeds come from, and large and diverse groups of researchers are questioning the long-term health of people and animals who consume the crops, and of people who consume the animals that have been raised on these crops. The information provided by these groups is less available but growing.

“The big picture looks at the people of the USA, who adopted GMO crops early and widely. Their once healthy and robust population is now plagued with increases in obesity, diabetes, cancers, food allergies, and dementia. Have GMO crops brought this on? That is easy to question and difficult to prove. I am a hobby farmer. I grow some “heritage” plants; so I can recover my own seeds for next years plantings. I also grow some hybrids getting nicer fruits and veggies and better yields; so I have voluntarily given up control of some of my seed sources. I have personally resisted using “no-till” GMO methods until the safety becomes clearer. That does not mean I am right; it only means that I am cautious.”

As an Independent Researcher and Consultant with Beyond Organic Consulting, Inc., Dr. Jana Bogs works in Hawaii and on the mainland with farmers, food and supplement manufacturers, and wholesalers and retailers–ensuring the absolute best quality products from farm to table. She has strong feelings about GMO crops.

“Top researchers who have studied the effects of these genetically-engineered ‘foods’ on laboratory animals found serious health risks associated with the consumption of these foods, such as tumors, lung damage, inability to reproduce, altered DNA function, immune responses commonly associated with diseases, significant organ disruptions, autistic-like behavior and early death,” explains Dr. Bogs. “Humans are also reported to have had serious negative consequences from GMOs. For example, some people have allergic reactions to GMO soybeans, but not to non-GMO soybeans. The American Academy of Environmental Medicine asks physicians to advise patients to avoid GMOs due to associated health risks. You may find it interesting to know that, in at least one cafeteria for employees at a Monsanto factory, GM soy and corn have such a bad reputation that they are not served.

“According to the Organic Consumers Association (OCA), genetic modification of crops has not increased yields. They cite a report sponsored by the United Nations (UN) and the World Bank, compiled by 400 scientists and endorsed by 58 countries which concluded, ‘GM crops have little to offer to the challenges of poverty, hunger, and climate change.’ Furthermore, the OCA states that scientists warn of potential dangers from the use of GMOs such as:

“The corporate whitewashing used to ‘sell’ GMO to governmental authorities and the public claims that genetic modification is a good and necessary action to produce more and/or higher quality foods to feed a hungry world. Often the genetic modifications are an attempt to circumvent a disease condition in the plants. Unfortunately, what has been seen is other plant disease conditions, which used to be minor concerns, becoming more serious due to the plants’ overall diminished cellular integrity. I contend there is nothing wrong with the natural plant genetics; it is the soils that have not been properly managed to supply the plants with nutrients they need to be healthy and resist diseases. These same nutrients are needed in the plants for humans to be able to consume them and be healthy as well. The bottom line is we do not need genetically engineered foods to feed the world; we need well-grown food.”

The Zintro blog will follow up with more information about the future of GMO crops. Earlier this month, the White House decided to appoint three U.S. agencies to review the regulation regarding biotech crop products. The President’s Office of Science and Technology made the decision as a result of many requests from consumers and various organizations.

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity:

I represent a commercial interest in California. We share a large building with another commercial venture. The structure for utilities distribution and billing was set up 30 years ago. I seek an energy consultant to look at our arrangement and recommend improvements/modifications relative to delivery and billing of Gas, electrical and water services.

According to an annual report from PG Economics, farmers in developing countries can benefit from GMO crops, particularly corn, soybeans, cotton, and canola. The report–GM crops: global socio-economic and environmental impacts 1996-2013–noted that global plantings grew to a record 416 million shares in 2013. Since 1996, the net economic benefit of crop biotechnology at the farm level has been $133.5 billion.

Graham Brookes, co-author of the report and director of PG Economics, said, “GM technology has continued to provide more productive agriculture, higher incomes to farmers and a better environment with citizens. A majority of these benefits continue to go to farmers and rural communities in developing countries.”

We asked Zintro experts to respond to the report. This post is the first of two posts featuring those responses.

Zintro expert Marcelo Huarte has experience with multinational groups such as GILB and World Potato Congress. He participated on GMO discussions with the G-8 and Workshop on Transgenic Potatoes for the benefit of resource-poor farmers in developing countries.

“GMO technology, as many others (i.g. vaccines in the XIX century) is not good or bad per se,” explains Huarte. “Reluctance to adopt new technologies is embedded in human nature. Political, as well as religious issues, have been an usual hurdle to overcome. No other agricultural technology has been worse marketed as GMO. GMO is related to large multinational companies and patent issues that oblige low-income farmers to them with the negative political impact that comes with it.

“Genes from the same species can be introduced with the same technology without the risks of alien genes. Agrochemicals receive a much milder opposition than GMOs although they might have larger impacts on health and environment. Most GMOs need fewer agrochemicals for their cultivation. Health risks due to the presence of antibiotics in transformed plants have been largely overcome and little effort has been done on the public domain to free GMO technology from the political issues presented above.”

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity:

]]>https://blog.zintro.com/2015/07/21/crop-biotechnology-impact-on-developing-countries-part-1/feed/0Inquiry Roundup-Food Sciencehttps://blog.zintro.com/2015/07/17/inquiry-roundup-food-science-3/
https://blog.zintro.com/2015/07/17/inquiry-roundup-food-science-3/#respondFri, 17 Jul 2015 21:52:28 +0000https://blog.zintro.com/?p=24131Food Science Hi, We are a start-up condiment company that is looking for a food scientist, who preferbably has access to a testing facility to test our ingredients, run a... Read More

We are a start-up condiment company that is looking for a food scientist, who preferbably has access to a testing facility to test our ingredients, run a food analysis (pH, temperature, consistency, etc.). [Having access to a food facility is not necessary if you have all the right equipment). We are a very small company and on a tight budget but I’m sure we can work on the pricing.View Inquiry

We are looking at (4) – (5) cold pressed juice options, powder (that we can toss into a granola mix, place on desserts and popcorn), bedtime snacks that can aid with digestion and sleep etc.View Inquiry

]]>https://blog.zintro.com/2015/07/17/inquiry-roundup-food-science-3/feed/0Success Story: John Verdonehttps://blog.zintro.com/2015/07/17/success-story-john-verdone/
https://blog.zintro.com/2015/07/17/success-story-john-verdone/#respondFri, 17 Jul 2015 20:45:28 +0000https://blog.zintro.com/?p=24126Zintro expert John Verdone is a coatings chemist/formulator with 27 years of experience in the coatings industry. During that time, he has formulated many coatings over a wide range of... Read More

]]>Zintro expert John Verdone is a coatings chemist/formulator with 27 years of experience in the coatings industry. During that time, he has formulated many coatings over a wide range of substrates. A graduate of the College of Central Florida, John specializes in formulation, quality control, research & development, lab equipment maintenance and color matching.

John has had considerable success working with clients on the Zintro platform. He recently discussed his experience assisting a Zintro client. “It was very satisfying to use my coatings background to help out the client. He was very happy with my work.”

Due to his satisfaction with the Zintro process, John plans on working on additional projects. He explains, “Zintro offers a nice service. Everything went very smoothly. I look forward to helping out future clients.”

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity:

]]>https://blog.zintro.com/2015/07/17/success-story-john-verdone/feed/0Inquiry Roundup – Food Manufacturinghttps://blog.zintro.com/2015/07/10/inquiry-roundup-food-manufacturing/
https://blog.zintro.com/2015/07/10/inquiry-roundup-food-manufacturing/#respondFri, 10 Jul 2015 21:25:42 +0000https://blog.zintro.com/?p=24116Pet Food Manufacturing In South Korea I would like to know the list of local and international pet food manufacturing units in South Korea along with their brand names. Further,... Read More

We are conducting a study to understand the ‘Food Flavour Market’. We are trying to understand the flavors sourcing strategies of some of the key Food and Beverages companies such as Fox’s, Kellogg, Nestle, Mondelez, Burton’s Biscuits, Mars, Unilever, Premier Foods, Walker Snack Food, etc. globally. For this study, we would like to connect with you over a paid telephonic consultation. We would be happy to compensate GBP 100-125 per hour for your time.

Hi,
We are a start-up condiment company that is looking for a food scientist, who preferbably has access to a testing facility to test our ingredients, run a food analysis (pH, temperature, consistency, etc.). [Having access to a food facility is not necessary if you have all the right equipment). We are a very small company and on a tight budget but I’m sure we can work on the pricing.

]]>https://blog.zintro.com/2015/07/10/inquiry-roundup-food-manufacturing/feed/0Inquiry Roundup- Construction Engineeringhttps://blog.zintro.com/2015/07/03/inquiry-roundup-construction-engineering-2/
https://blog.zintro.com/2015/07/03/inquiry-roundup-construction-engineering-2/#respondFri, 03 Jul 2015 21:59:53 +0000https://blog.zintro.com/?p=24101Highway Construction As Founder of a newly formed non profit Christian organization am looking for a highway engineering professional who has worked for several years as a general contractor managing... Read More

As Founder of a newly formed non profit Christian organization am looking for a highway engineering professional who has worked for several years as a general contractor managing and coordinating large construction projects. This organization will operate projects all across Africa. Assistance is sought to write a Business plan and help develop structures and modalities for project management and implementation.

One of our prestigious client a World Class Player in infrastructure projects is looking for a senior civil engineering professional with a great experience in TBM for their metro constructionprojects in India.

]]>https://blog.zintro.com/2015/07/03/inquiry-roundup-construction-engineering-2/feed/0Massachusetts’ Role in the Biotech Markethttps://blog.zintro.com/2015/07/02/massachusetts-role-in-the-biotech-market/
https://blog.zintro.com/2015/07/02/massachusetts-role-in-the-biotech-market/#respondThu, 02 Jul 2015 21:04:52 +0000https://blog.zintro.com/?p=24066A Massachusetts state agency approved $2.2 million in grants this month to fund startups that reach early-stage milestones. The move stems from an identified gap in the Bay State’s booming... Read More

]]>A Massachusetts state agency approved $2.2 million in grants this month to fund startups that reach early-stage milestones. The move stems from an identified gap in the Bay State’s booming biotech market.

According to Susan Windham-Bannister, the outgoing president of the Massachusetts Life Sciences Center, “This was a gap in which Massachusetts often loses companies to other states.”

Although the center provides grants to early-stage companies to reimburse them for hiring interns, this is the first time it’s given grants to companies to help them achieve early milestones–including prototype development, market analysis, clinical trials, and business plan development. From 98 applicants, the center awarded 12 state-sponsored grants of between $50,000 to $200,000.

Zintro expert Michael L. Salgaller, Ph.D. is an experienced biopharma, healthcare, and venture capital executive in senior management. He explains, “Such state-sponsored economic development activities have a mixed record of success in producing successful entrepreneurial activity in the biotech sector. In Maryland, the Technology Economic Development Corporation (TEDCO), has been recognized for several years as the #1 funder of early-stage companies.

“Nonetheless, the state remains at the second-tier of biotech hubs. These types of funds do provide early validation, as well as critical support for proof-of-concept work and/or operation activities. Any many such companies go on to secure risk capital. However, there is little data that state economic development funds give life-blood to deserving companies that would have died otherwise.

“Many argue funds go to stronger companies that would have secured angel or high net-worth individual monies anyway. Investor tax credits and similar incentives have shown to generate additional and higher risk capital investment in states such as Maryland and California. States whose legislatures decided not to maintain such tax credit programs – including Washington – realize they are at a comparative disadvantage that $50K from a state program only partially overcomes.”

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity:

Project: improving of operational efficiency and productivity of a large petro chemical Russian company – producer of suspension PVC (polyvinylchloride) and caustic soda.

1. International expert with management experience in similar enterprises (preferably EU / US). Willingness to share knowledge on the organization of the main and auxiliary functions in enterprises, especially in the service / repair directly at the production sites.

2. Russian expert with a background in projects of a Production system of Sibur. Willingness to share knowledge on the implementation of lean production solutions for enterprises Sibur (production, maintenance and repair, warehouse logistics)

Seeking a consultant with experience in industrial cleaning formulations to evaluate existing formulations and to provide recommendations for improvement/customization to meet specific customer needs. Should have experience in cleaners for food processing equipment and other industrial cleaners.

]]>https://blog.zintro.com/2015/06/26/inquiry-roundup-chemical-engineering/feed/0Success Story: Simona Bodiuthttps://blog.zintro.com/2015/06/25/success-story-simona-bodiut/
https://blog.zintro.com/2015/06/25/success-story-simona-bodiut/#respondThu, 25 Jun 2015 18:31:06 +0000https://blog.zintro.com/?p=24025Zintro expert Simona Bodiut is a chartered/forensic accountant with extensive business and financial management experience. Her ability to adapt has made it possible to expand from Financial and HR to... Read More

]]>Zintro expert Simona Bodiut is a chartered/forensic accountant with extensive business and financial management experience. Her ability to adapt has made it possible to expand from Financial and HR to Procurement and Outsourcing projects among others. Simona has researched numerous projects. Examples of her research include:

“I’ve been very successful at meeting the needs of Zintro clients. The Zintro platform allows me to make effective use of my knowledge, skills and experience. In fact, Zintro has helped me to grow from a local operating business to a global business.”

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity:

]]>https://blog.zintro.com/2015/06/25/success-story-simona-bodiut/feed/0Zintro Feature Update: Close Inquiries + New Links + View Profile + Tools & Morehttps://blog.zintro.com/2015/06/23/zintro-feature-update-close-inquiries-new-links-view-profile-tools-more/
https://blog.zintro.com/2015/06/23/zintro-feature-update-close-inquiries-new-links-view-profile-tools-more/#respondTue, 23 Jun 2015 22:22:15 +0000https://blog.zintro.com/?p=24054Our Product and Engineering teams have been hard at work this past month building new features and updating existing ones. Here are some of the highlights below: 1) Direct... Read More

]]>Our Product and Engineering teams have been hard at work this past month building new features and updating existing ones. Here are some of the highlights below:

1) Direct inquiries no longer expire.
Found a good Expert? Keep your 1 to 1 conversation with that expert open indefinitely allowing you to continue to interact, engage and to make multiple payments over time.

2) Close Inquiries
Did you find who you were looking for or simply would like to stop receiving responses from new experts? Closing an inquiry makes it very easy. If you found someone for the job, the easiest way to let other experts know is to close the inquiry and start a new conversation with the expert you chose.

3) New LINKS section added to expert profiles along with automatic link import on expert signup
Experts can add various social profile or other relevant links to the expert profiles.

5) New TOOLS icons with description & Zintro fee calculator
Now experts can easily submit quotes with proposals to clients and see what their fee and the Zintro fee will be.

6) New payment tool in conversations along with streamlined payment process
a. Reduced number of fields
b. Easy to understand workflow
c. One step payments

7) Request to cancel payments
Your payment is in escrow, but you decided to no longer hire the expert? No problem, click the link and request a cancelation. Our conflict resolution team will get in touch with you as soon as possible and help you reach an agreement. We can now revert your payment in escrow.

We are looking into purchasing a machine to pack washed and processed leafy greens and herbs in clamshell packaging. I am looking for someone who can consult on the best options available for our operation.

We are a global research firm and an authorized Zintro partner looking for experts who could consult for a study on industrial animal feeds packaging.

The expert should have a background in animal feed production/ sales, and be in a position to speak about the usage (in proportion terms) of various bags and packaging solutions for various feeds (pig/ poultry/ cattle).

The expert needs to be available to consult with us via phone consultations. If interested, please contact me. Thanks!

]]>The Massachusetts Life Center recently approved $2.2 million in grants for biotech companies to reach early-stage milestones. The move is an attempt to fund startups earlier in their lifecycle. According to Susan Windham-Bannister, the outgoing president of the Massachusetts Life Center, the state often loses companies to other states.

Although the center has provided loans and grants in the past, this is the first time they are giving grants to companies to help them achieve early milestones. State-sponsored grants up to $200,000 were offered for the completion of such milestones as prototype development, market analysis, clinical trials or business plan development.

Ari Maayan is one of the original pioneers of the biotechnology industry in Massachusetts, at a time when it was still called industrial microbiology. Maayan explains, “I was employee #2 in Genzyme and employee #14 in Biogen. I was one of the founders of the Association of Biotechnology Companies, the flagship industry organization. I then started up American BioDesign, which was a consulting company that provided process design, product design and facilities design for start-up biotech companies. I also consulted to numerous VC and investment banking firms, providing technical and business due diligence on many of the start-up biotech companies in the Bay State.

“This was in the days when biotech start-up capital was plentiful and relatively easy to acquire. I have watched the process of the regression of biotech start-up capital since then. The need for the early stage “gap funding” is vital to the continuation of the role of leadership of the Bay State in the biotech industry. In today’s venture funding climate, the lack of such funding will strangle the start-up position of the State’s biotech industry.”

Michael Salgaller, Ph.D., President and COO Executive and Senior Management for Biopharma, shares his thoughts. “Such state-sponsored economic development activities have a mixed record of success in producing successful entrepreneurial activity in the biotech sector. In Maryland, the Technology Economic Development Corporation (TEDCO), has been recognized for several years as the #1 funder of early-stage companies. Nonetheless, the state remains at the second-tier of biotech hubs. These types of funds do provide early validation, as well as critical support for proof-of-concept work and/or operation activities. And many such companies go on to secure risk capital.

However, there is little data that state economic development funds give life-blood to deserving companies that would have died otherwise. Many argue funds go to stronger companies that would have secured angel or high net-worth individual monies anyway. Investor tax credits and similar incentives have shown to generate additional and higher risk capital investment in states such as Maryland and California. States whose legislatures decided not to maintain such tax credit programs – including Washington – realize they are at a comparative disadvantage that $50K from a state program only partially overcomes.”

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity:

We are starting a medical device company related to IVD (its a blood glucose monitoring wearable). We want to make sure to do the right things from the beginning. We would request your quote and timeline on all the following:

1. 510k submission for our Class II – we want someone who can guide on 510k, write the submission, correspond with the FDA and get clearance for us.

2. Quality systems- Write all SOPs for us per the FDA, train our employees on all the SOPs

We are manufacturers and exporters of medical devices (IOLs), Disposable Blades and other instruments and supplies. We are looking for distributors in all major countries. Currently we are focusing on South and Central American countries (Latin America). However we are open for other countries as well. We have ISO and CE Mark to our products. Our instrument line of products have even USA FDA registration. We offer excellent combination of good quality and excellent prices. If interested contact us.

]]>Researchers at the Fralin Life Science Institute at Virginia Tech have identified a gene responsible for sex determination in mosquito that transmit yellow fever, dengue, and chikungunya viruses. Researchers think that because only female mosquitoes bite (because blood is needed for developing eggs), a higher ratio of males may reduce the transmission of these diseases. The scientists identified a male-determining gene in a study published in Science Express.

Scientist Kranthi Paladugu, who has experience working with DNA and RNA in Research & Development, finds the study great news. “It is certainly an important development and may be a useful diagnostic marker in sex determination. However, population dynamics also play a role. Developing sterile female mosquito population methods or technology may be an alternate idea, but the natural population is always a daunting task.”

Swapna Menon, a Genomics Data Analyst & Biocurator, brings up several issues. “First, consider the justification of spending government money and resources on production and dissemination of transgenic mosquitoes versus raising public awareness of common sense approaches to mosquito breeding and mosquito bites prevention.

“There is also the question of the ecological effects of such intervention and the scientific evidence, or lack thereof, for effect or non-effect of the mosquito female population control in the urban habitat. In addition, it’s important to look at precedents of success or failure in such approaches in controlling the vector population.”

Postdoctoral Fellow Eduardo Cardenas agrees on the importance of considering related issues. “Many questions must be addressed. How would you modulate gene expression and when? Would it be less toxic than current pesticides? What are the repercussions of altering gender type in population? What about the ecosystem–the animals that rely heavily on mosquitoes as a food source? Is there even a candidate compound to modulate this gene?”

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity:

I hope this message finds you well. I am currently working on a project focusing in the Chemical industry and I would like to get in touch in order to offer you a very short phone consultation at your convenience.

We are developing a technology for aroma chemical manufacturing. Chemical is well known but raw material and manufacturing process are different. There are different impurities in our product and some of them may have odor. We are looking for expert/perfumer help with testing the odors of the samples to define which impurities affect the odor of our product.

]]>https://blog.zintro.com/2015/06/05/inquiry-roundup-chemical-manufacturing/feed/0Drugmakers and Insurers Attempt to Collaborate on Medication Priceshttps://blog.zintro.com/2015/06/04/drugmakers-and-insurers-attempt-to-collaborate-on-medication-prices/
https://blog.zintro.com/2015/06/04/drugmakers-and-insurers-attempt-to-collaborate-on-medication-prices/#respondThu, 04 Jun 2015 20:25:58 +0000https://blog.zintro.com/?p=23969An increasing number of drugmakers, including Biogen Inc., Amgen Inc., and Sanofi are taking a proactive marketing approach–talking with insurers about costly medications still under development. With the price of these... Read More

]]>An increasing number of drugmakers, including Biogen Inc., Amgen Inc., and Sanofi are taking a proactive marketing approach–talking with insurers about costly medications still under development. With the price of these medications reaching into the six figures, drugmakers are hoping to convince insurers to pay for future therapies by reaching out beforehand.

This trend is a result of the Gilead Sciences, Inc.’s experience In December 2013 when the media reported that its hepatitis C treatment Solvadi would cost $84,000 (or $1,000 per pill). House Democrats reacted and in the end the largest manager of drug benefits in the U.S. backed a rival drug with a lesser price tag.

We asked Zintro experts in the industry what they thought about the situation.

Amr Bannis is the President and CEO of a progressive high technology corporation. In 1999 he developed the first Canadian Online Pharmacy and has since been closely connected to the pricing policies of big pharma.

“In the last couple of years all blockbuster medications lost their patents and big pharma consequently lost their huge margin. But to be fair, the past drugs were maintenance drugs taken for the rest of patients’ lives–so although their unit prices were low in comparison, their present value was very high. Now big pharma needs to replace their cash cow, jumping on biologics and specialty drugs and pricing them based on their value rather than their cost plus. Looking closely, the present value of some pricey gene therapies and specialty drugs may be less costly than the previous generation of blockbuster drugs of the past 20 years.”

Harold M. Silverman, Pharm,D. is a pharmacist with extensive hospital pharmacy experience. He is also the author of several consumer health books including “The Pill Book.” With 15 editions and more than 17 million copies in print, it is the most widely sold consumer reference on prescription medications.

“Prescription drug pricing and availability have been political footballs for decades, beginning with hearings held by the Senate Committee on Aging in the eighties, through today’s congressional concerns over the cost of generic pharmaceuticals, the promotion of biosimilars expressly designed to create competitively priced alternatives, to widely prescribed biologic medicines, and the push by patient groups to make high-cost orphan and other drugs designed to treat relatively rare diseases available to patients who see them as lifesaving interventions even though they may not be and also carry significant risks. It is extremely important for companies with products which fit this description to take every possible step to have their products included on the formularies of as many health insurers as possible, especially Medicare and Medicaid, the nation’s largest providers of health insurance services.”

Drugmakers continue to negotiate with insurers as they await FDA approval for the next wave of medications. Bloomberg.com reports that the collaborative approach appears to be working.

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity:

Hi,
I require a flavorost to help me with 1 ingredient that I can’t quite put my finger on. I’m trying to match the sweet flavour from a popular alcohol brand. I’m producing a more affordable brand but can’t seem to put my finger on the sweet/candy taste. Might be easy for a professional to figure this one. Need help ASAP. BrandonView Inquiry

I am looking for a flavorist that can help me with developing a product. The key things i need is for the flavorist to help with creating the right base (should i use extracts,oils,powder,liquids etc). Also advice on the delivery system used. I also will be most likely be dealing with flavor companies, supplies etcView Inquiry

Zintro Webinar

Presenter’s Note:
“Many Pharmaceutical Companies are engaging in the outsourcing of the Pharmacovigilance. In doing so, what are the key drivers and pitfalls in conducting such activities outside of the Company. Who ultimately makes the decision regarding the choice of the outsourcing partner and if it goes wrong, who is to blame?
What can be done to avoid making a bad decision as well as ensuring that once the choice has been made that a compliant system is in operation? The webinar is intended to show what the Regulators expect to see when they review the Pharmacovigilance activities.”

About Graeme Ladds:
Graeme Ladds started his science career with a Degree in Biochemistry and Pharmacology and then a PhD in drug metabolism and Pharmacokinetics. He has been involved in Global Pharmacovigilance and Medical Information for the last 25 years. His last role in Industry was as Global Head of Pharmacovigilance and that was before he started PharSafer – a Specialist Global PV & Medical Services provider where he has been for the last 12 years.

Other useful links

]]>https://blog.zintro.com/2015/05/28/pharmacovigilance-outsourcing-the-dos-and-donts-presented-by-graeme-ladds/feed/03 Productivity Killers for Consultantshttps://blog.zintro.com/2015/05/26/3-productivity-killers-for-consultants/
https://blog.zintro.com/2015/05/26/3-productivity-killers-for-consultants/#respondTue, 26 May 2015 20:33:16 +0000https://blog.zintro.com/?p=23946One of the top benefits of being a consultant or freelancer is having control over your time. However, unless you know how to manage your time, success can be elusive.... Read More

]]>One of the top benefits of being a consultant or freelancer is having control over your time. However, unless you know how to manage your time, success can be elusive. Here are five pitfalls to avoid when self-motivation and personal accountability are critical:

1. Procrastination

Putting off assignments until the last minute is never a good idea, no matter what your position. But when you don’t have a manager keeping you accountable, it is easy to become a victim to procrastination. You may believe that you create your best work under pressure, but chances are you are sacrificing quality. Set aside enough time to complete a project well and you will avoid making mistakes–and missing a deadline.

Tip: If you put off projects on a consistent basis, the Avoiding Procrastination 101 app on Google Play may be the answer. It helps you identify the root of your procrastinating behavior and provides suggestions to help you turn it around.

2. Social media

Don’t fool yourself into thinking you’ll just take a quick peek at your Facebook timeline and then get started on the day’s tasks. The concept of time disappears once you are logged into, any social media site. If you really want to take a quick break online, set a timer or other reminder for five minutes, so you don’t waste valuable time.

Tip: Strict Workflow for Chrome enforces a 25 min/5 min workflow. Every 25 minutes is followed by a 5-minute break. Start the timer with just one click.3. Disorganization

How many minutes have you wasted looking for an important document on your messy desk? An uncluttered workspace doesn’t just look nice–it saves time. Plus, you’re much more likely to be productive when everything you need is accessible, but not in a jumbled pile in front of you. It doesn’t need to be spotless, but distracting paperwork should be neatly filed away so you can focus on your current assignment.

Tip: Things is an iStore app that breaks down tasks into achievable, bite-sized bits. You also get a printable daily checklist to help you get your schedule under control.

As a consultant or freelancer, you have more independence than most people. The trick is to take the responsibility of this freedom seriously. After all, the more productive you are, the more successful your business will be.